Beta Bionics, Inc. Operating Income
Beta Bionics, Inc. (BBNX) reported Operating Income of -$25.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-29
- Beta Bionics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$25.58M.
- Beta Bionics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$24.27M.
- Beta Bionics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$16.12M.
- Beta Bionics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$17.04M.
- Beta Bionics, Inc. operating income (loss) for fiscal 2025 was -$71.68M.
- Beta Bionics, Inc. operating income (loss) for fiscal 2024 was -$45.25M.
- Beta Bionics, Inc. operating income (loss) for fiscal 2023 was -$35.85M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.58M 10-Q · filed 2026-07-29 | -$49.85M 10-Q · filed 2026-07-29 | -$65.97M derived: sum of 3 quarters · filed 2026-07-29 | -$83.02M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$24.27M 10-Q · filed 2026-04-21 | -$40.40M derived: sum of 2 quarters · filed 2026-04-21 | -$57.44M derived: sum of 3 quarters · filed 2026-04-21 | -$77.31M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$16.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$33.17M derived: sum of 2 quarters · filed 2026-02-24 | -$53.04M derived: sum of 3 quarters · filed 2026-07-29 | -$71.68M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$17.04M 10-Q · filed 2025-10-28 | -$36.91M derived: sum of 2 quarters · filed 2026-07-29 | -$55.56M 10-Q · filed 2025-10-28 | -$68.59M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$19.87M 10-Q · filed 2026-07-29 | -$38.51M 10-Q · filed 2026-07-29 | -$51.55M derived: sum of 3 quarters · filed 2026-07-29 | -$62.53M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$18.64M 10-Q · filed 2026-04-21 | -$31.68M derived: sum of 2 quarters · filed 2026-04-21 | -$42.66M derived: sum of 3 quarters · filed 2026-04-21 | -$54.44M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | -$13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$24.01M derived: sum of 2 quarters · filed 2026-02-24 | -$35.80M derived: sum of 3 quarters · filed 2026-02-24 | -$45.25M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$10.98M 10-Q · filed 2025-10-28 | -$22.76M derived: sum of 2 quarters · filed 2025-10-28 | -$32.21M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | -$11.78M 10-Q · filed 2025-07-29 | -$21.24M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | -$9.45M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | -$35.85M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |